Patents by Inventor Ravi Anantha

Ravi Anantha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
    Publication number: 20240150789
    Abstract: The present disclosure provides cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: October 27, 2023
    Publication date: May 9, 2024
    Inventors: Thomas G. Evans, Ravi Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Tuberculosis Compositions And Methods Of Using The Same
    Publication number: 20240101612
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: September 6, 2023
    Publication date: March 28, 2024
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Recombinant cytomegalovirus vectors as vaccines for tuberculosis
    Patent number: 11834669
    Abstract: Disclosed herein are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: December 5, 2023
    Assignees: International AIDS Vaccine Initiative, Inc., Oregon Health and Science University
    Inventors: Thomas G. Evans, Ravi Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Tuberculosis compositions and methods of using the same
    Patent number: 11787842
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: October 17, 2023
    Assignee: International AIDS Vaccine Initiative, Inc.
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
    Publication number: 20210403951
    Abstract: The present disclosure provides cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: July 1, 2021
    Publication date: December 30, 2021
    Inventors: Thomas G. Evans, Ravi Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Tuberculosis Compositions And Methods Of Using The Same
    Publication number: 20210371474
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: April 21, 2021
    Publication date: December 2, 2021
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Tuberculosis compositions and methods of using the same
    Patent number: 11014969
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: May 25, 2021
    Assignee: International AIDS Vaccine Initiative, Inc.
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Tuberculosis Compositions And Methods Of Using The Same
    Publication number: 20190322709
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: March 1, 2019
    Publication date: October 24, 2019
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Tuberculosis compositions and methods of using the same
    Patent number: 10266574
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: April 23, 2019
    Assignee: International AIDS Vaccine Initiative, Inc.
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker
  • Tuberculosis Compositions And Methods Of Using The Same
    Publication number: 20140377300
    Abstract: The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: June 24, 2014
    Publication date: December 25, 2014
    Inventors: Ravi Anantha, Nathalie Cadieux, Thomas G. Evans, Michele Stone, Barry Walker